Eiko Lifesciences has informed that as required under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of Board of Directors of the Company is scheduled to be held on Monday, 13th May,2024, to consider and approve the following: The Audited Financial Results of the Company for the quarter and financial year ending on 31st March,2024 in accordance with Regulation 33 of the SEBI Listing Regulation; Any other matter with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.